A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants

PHASE3CompletedINTERVENTIONAL
Enrollment

259

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Masseter Muscle Prominence
Interventions
DRUG

BOTOX

Intramuscular Injection

DRUG

Placebo for BOTOX

Intramuscular Injection

Trial Locations (18)

810-0022

Jyosui Dermatology Clinic /ID# 254300, Fukuoka

063-0812

Kotoni Tower Skin And Cosmetic Surgery Clinic /ID# 260668, Sapporo

259-1193

Tokai University Hospital /ID# 254204, Isehara

604-8035

Yoshikawa Skin Ecru Clinic /ID# 256505, Kyoto

900-0015

Touyama Plastic Surgery Clinic /ID# 254831, Naha

593-8324

Dermatology and Ophthalmology Kume Clinic /ID# 254632, Sakai-shi

426-0067

Skin Clinic Fujieda /ID# 254214, Fujieda-shi

103-0027

Tokyo Center Clinic /ID# 254775, Chuo-ku

104-0031

Tokyo Asbo Clinic /ID# 257728, Chuo-ku

104-0061

Ginza Skin Clinic /ID# 254666, Chuo-ku

152-0023

Jiyugaoka Clinic /ID# 256666, Meguro-ku

106-0032

Azabu beauty clinic /ID# 254519, Minato

Roppongi Imaizumi Skin Clinic /ID# 254573, Minato-ku

108-8642

Kitasato University Kitasato Institute Hospital /ID# 255369, Minato-ku

190-0023

Greenwood Skin Clinic Tachikawa /ID# 254830, Tachikawa-shi

171-0021

Ikebukuronishiguchi Fukurou Dermatology Clinic /ID# 254639, Toshima-ku

380-0826

Jun Clinic /Id# 254870, Nagano

333-0055

Chiharu Dermatology Clinic Urawa /ID# 254778, Saitama

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY